Your browser doesn't support javascript.
loading
Efficacy and safety of nivolumab in non-small cell lung cancer with preexisting interstitial lung disease.
Kanai, Osamu; Kim, Young Hak; Demura, Yoshiki; Kanai, Makiko; Ito, Tsuyoshi; Fujita, Kohei; Yoshida, Hironori; Akai, Masaya; Mio, Tadashi; Hirai, Toyohiro.
Afiliación
  • Kanai O; Division of Respiratory Medicine, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Kim YH; Department of Respiratory Medicine, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
  • Demura Y; Department of Respiratory Medicine, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
  • Kanai M; Department of Respiratory Medicine, Japanese Red Cross Fukui Hospital, Fukui, Japan.
  • Ito T; Division of Respiratory Medicine, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Fujita K; Panasonic Health Insurance Organization, Kadoma, Japan.
  • Yoshida H; Division of Radiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Akai M; Division of Respiratory Medicine, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Mio T; Department of Respiratory Medicine, Graduate school of Medicine, Kyoto University, Kyoto, Japan.
  • Hirai T; Department of Respiratory Medicine, Japanese Red Cross Fukui Hospital, Fukui, Japan.
Thorac Cancer ; 9(7): 847-855, 2018 07.
Article en En | MEDLINE | ID: mdl-29782069

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Pulmonares Intersticiales / Carcinoma de Pulmón de Células no Pequeñas / Nivolumab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Thorac Cancer Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Singapur

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Enfermedades Pulmonares Intersticiales / Carcinoma de Pulmón de Células no Pequeñas / Nivolumab Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Thorac Cancer Año: 2018 Tipo del documento: Article País de afiliación: Japón Pais de publicación: Singapur